- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00977938
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subjects with ischemic heart disease due to stenotic lesions in either native coronary arteries or coronary artery bypass grafts undergoing percutaneous coronary intervention (PCI) with stent placement and no contraindications to prolonged dual antiplatelet therapy are eligible to be enrolled in the study.
All enrolled subjects will undergo PCI with stent placement. All enrolled subjects will be treated with either an FDA-approved drug eluting stent(s) (DES) or an FDA-approved bare metal stent(s) (BMS) (per their respective Instructions for Use) and assigned to 12 months of open label FDA-approved thienopyridine treatment in addition to aspirin. Operators will select the thienopyridine according to the package insert. Thienopyridine treatment dose will be according to the standard of practice and prescribing information for the selected medication. Aspirin treatment will be 75-325 mg for the first 6 months after the procedure and 75-162 mg subsequently, to be continued indefinitely. All DES or BMS subjects who are treated with 12 months of dual antiplatelet therapy post index procedure and who are event free per protocol will be eligible for randomization to either placebo (12 m DAPT Study arm) or an additional 18 months of thienopyridine treatment (30 m DAPT Study arm). Both arms will continue aspirin therapy.
Up to four (4) separate post-market approval studies will be allowed to incorporate the randomized design of the DAPT Study for a subset of subjects who may then be contributed for the DAPT Study analyses.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Clayton, Australia, 3168
- Monash Heart
-
Fitzroy, Australia, 3065
- St Vincents Hospital Melbourne
-
-
New South Wales
-
Darlinghurst, New South Wales, Australia, 2010
- St. Vincents Hospital Sydney
-
Randwick, New South Wales, Australia, 2031
- Prince of Wales Eastern Heart
-
-
South Australia
-
Adelaide, South Australia, Australia, 5000
- Royal Adelaide Hospital
-
-
Victoria
-
Prahran, Victoria, Australia, 3004
- The Alfred Hospital
-
-
Western Australia
-
Fremantle, Western Australia, Australia, 6160
- Fremantle Hospital
-
Nedlands, Western Australia, Australia, 6009
- The Mount Hospital
-
Perth, Western Australia, Australia, 6000
- Royal Perth Hospital
-
-
-
-
-
Hradec Kralove, Czechia, 500 05
- Fakultni nemocnice Hradec Kralove
-
Karlovy Vary, Czechia, 360 66
- Krajska karlovarska nemocnice a.s.
-
Kromeriz, Czechia, 767 01
- Centrum pro choroby srdce a cev
-
Ostrava, Czechia, 701 00
- Mestska nemocnice Ostrava
-
Zlin, Czechia, 76275
- Krajska nemocnice T. Bati a.s.
-
-
-
-
-
La Rochelle, France, 17000
- Centre hospitalier Saint Louis
-
Lomme, France, 59462
- Hospital Saint Philibert
-
Nantes, France, 44277
- Nouvelles Cliniques Nantaises
-
Nimes, France, 30000
- Clinique Les Franciscaines
-
Paris, France, 75018
- Hôpital Bichat
-
Pessac, France, 33604
- Groupe Hospitalier Sud
-
Tourcoing, France, 59208
- CH Chatiliez Tourcoing
-
-
-
-
-
Berlin, Germany, 10249
- Vivantes Klinikum im Friedrichshain
-
Berlin, Germany, 12351
- Vivantes-Klinikum Neukoelin
-
Berlin, Germany, 13437
- Vivantes-Klinikum Neukoelln
-
Berlin, Germany, 13509
- Vivantes-Humboldt Klinikum
-
Buxtehude, Germany, 21614
- Elbe-Kliniken Stade-Buxtehude GmbH
-
Dresden, Germany, 01307
- Universitaetsklinikum Dresden
-
Hamburg, Germany, 20099
- Asklepios Klinik St. Georg
-
Leipzig, Germany, 4289
- Herzzentrum Leipzig GmbH
-
Stade, Germany, 21682
- Elbe-Kliniken Stade-Buxtehude GmbH
-
-
BE
-
Berlin, BE, Germany, 1
- Helios Klinikum Emil Von Behring
-
-
SH
-
Luebeck, SH, Germany, 23538
- Universitaetsklinikum Schleswig-Holstein - PS
-
-
-
-
-
Budapest, Hungary, 1096
- Gottsegen György Országos Kardiológiai Intézet
-
Nyiregyhaza, Hungary, 4400
- Josa Andras Oktato Korhaz Nonprofit Kft
-
Pecs, Hungary
- Pécsi Tudományegyetem Klinikai Központ
-
Szeged, Hungary, 6720
- Szegedi Tudomanyegyetem Szent-Gyorgyi Klinikai Kozpont
-
Zalaegerszeg, Hungary, 8900
- Zala Megyei Kórház
-
-
-
-
-
Auckland, New Zealand
- Middlemore Hospital
-
Auckland, New Zealand, 0622
- North Shore Hospital
-
Auckland, New Zealand
- Ascot Hospital
-
Christchurch, New Zealand, 8001
- Christchurch Hospital
-
Hamilton, New Zealand, 3240
- Waikato Hospital
-
Nelson, New Zealand
- Nelson Hospital
-
Wellington, New Zealand, 6021
- Wellington Hospital
-
Wellington, New Zealand, 6039
- Wakefield Hospital
-
-
Auckland
-
Epsom, Auckland, New Zealand, 00000
- Mercy Angiography
-
-
-
-
-
Bialystok, Poland, 15-276
- Uniwersyteck Szpital Klin. w Bialymstoku
-
Bydgoszcz, Poland, 85-826
- Wielospecj. Szpital Miejski im.dr.E.Warminskiego-SPZOZ
-
Krakow, Poland, 31-501
- Szpital Uniwersytecki w Krakowie
-
Krakow, Poland, 30-069
- NZOZ Centrum Medyczne Beluga-Med
-
Szczecin, Poland, 70-111
- SPSK nr 2 Pomorskiej Akademii Medycznej w Szczecinie
-
Ustron, Poland, 43-450
- Polsko-Amerykanskie Kliniki Serca.American Heart of Poland S
-
Warszawa, Poland, 04-637
- Instytut Kardiologii im. Kardynala St. Wyszynskiego
-
-
-
-
-
Bucuresti, Romania, 10242
- Centrul Clinic de Urgenta de Boli Cardiovasculare al Armatei
-
Bucuresti, Romania, 14461
- Spitalul Clinic de Urgenta Bucuresti
-
Bucuresti, Romania, 22328
- Inst. Urgenta Boli Cardiovasculare Prof. Dr. C.C. Iliescu
-
Bucuresti, Romania, 22328
- Institutul de Urgenta pentru Boli Cardiovasculare Prof. Dr.
-
Bucuresti, Romania, 50098
- Spitalul Clinic Universitar de Urgenta Bucuresti
-
Cluj-Napoca, Romania, 400001
- Institutul Inimii Niculae Stancioiu Cluj-Napoca
-
Targu Mures, Romania, 540136
- Institutul de Boli Cardiovasculare si Transplant Targu Mures
-
-
-
-
-
Chertsey, United Kingdom, KT16 OPZ
- St Peter's Hospital
-
Coventry, United Kingdom, CV2 2DX
- University Hospital of Coventry and Warwickshire
-
Dundee, United Kingdom, DD1 9SY
- Ninewells Hospital
-
Edinburgh, United Kingdom, EH16 4SA
- Royal Infirmary of Edinburgh
-
Leicester, United Kingdom, LE3 9QP
- University Hospital of Leicester Glenfield Hospital
-
London, United Kingdom, E2 9JX
- The London Chest Hospital
-
Newcastle, United Kingdom, NE7 7AW
- Freeman Hospital
-
Plymouth, United Kingdom, PL6 8DH
- Derriford Hospital
-
-
Bucks
-
High Wycombe, Bucks, United Kingdom, HP11 2TT
- Wycombe General Hospital
-
-
Cambs
-
Cambridge, Cambs, United Kingdom, CB3 8RE
- Papworth Hospital
-
-
Devon
-
Torquay, Devon, United Kingdom, TQ2 7AA
- Torbay Hospital
-
-
Dorset
-
Bournemouth, Dorset, United Kingdom, BH7 7DW
- Royal Bournemouth General Hospital
-
-
Essex
-
Basildon, Essex, United Kingdom, SS16 5NL
- Basildon University Hospital
-
-
Herts
-
Barnet, Herts, United Kingdom, EN5 3DJ
- Barnet Hospital
-
-
N York
-
Middlesborough, N York, United Kingdom, TS4 3BW
- James Cook Hospital
-
-
Scotland
-
Dundee, Scotland, United Kingdom, DD1 9SY
- Ninewells Hospital
-
-
Somerset
-
Weston Super Mare, Somerset, United Kingdom, BS23 4TQ
- Weston General Hospital
-
-
Strath
-
Glasgow, Strath, United Kingdom, F81 4HX
- Golden Jubilee National Hospital
-
-
-
-
Alabama
-
Fairhope, Alabama, United States, 36532
- Thomas Hospital
-
-
Arizona
-
Gilbert, Arizona, United States, 85297
- Mercy Gilbert Medical Center
-
Phoenix, Arizona, United States, 85006
- Heart & Vascular Center of Arizona
-
Scottsdale, Arizona, United States, 85258
- Scottsdale Health Care
-
-
Arkansas
-
Jonesboro, Arkansas, United States, 72401
- NEA Baptist Clinic
-
Little Rock, Arkansas, United States, 72211
- Arkansas Heart Hospital
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas (Central VA) for Medical Science
-
-
California
-
Fremont, California, United States, 94538
- California Cardiovascular Consultants/ Washington Hospital
-
La Jolla, California, United States, 92037
- The Foundation for Cardiovascular Medicine
-
Sacramento, California, United States, 95819
- Mercy General Hospital
-
San Diego, California, United States, 92103-8784
- UC San Diego Medical Center
-
San Francisco, California, United States, 94115
- California Pacific Medical Center
-
Stockton, California, United States, 95204-6088
- St. Joseph's Medical Center- CA
-
Torrance, California, United States, 90509
- Harbor - UCLA Medical Center
-
Torrance, California, United States, 90505
- Torrance Memorial Medical Center / Vasek Polak Research Program
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- Medical Center of Aurora
-
-
Connecticut
-
Bridgeport, Connecticut, United States, 06610
- Bridgeport Hospital
-
Bridgeport, Connecticut, United States, 06606
- Connecticut Clinical Research, Llc
-
Stamford, Connecticut, United States, 06905
- St. Vincent's Medical Center
-
-
District of Columbia
-
Washington, D.C., District of Columbia, United States, 20010
- Washington Hospital Center
-
-
Florida
-
Atlantis, Florida, United States, 33462
- Palm Beach Heart Research Institute
-
Brandon, Florida, United States, 33511
- Bay Area Cardiology Associates/ Brandon Regional Hospital
-
Jacksonville, Florida, United States, 32207
- Jacksonville Heart Center
-
Lakeland, Florida, United States, 33805
- Watson Clinic Center for Research
-
Lauderdale Lakes, Florida, United States, 33313
- Diagnostic Cardiology Associates
-
Melbourne, Florida, United States, 32901
- Melbourne Internal Medicine Assoc
-
Miami, Florida, United States, 33176
- Baptist Hospital of Miami
-
Ocala, Florida, United States, 34471
- Munroe Regional Medical Center
-
Ocala, Florida, United States, 34480
- Ocala Regional Medical Center
-
Orlando, Florida, United States, 32803
- Florida Hospital
-
Pensacola, Florida, United States, 32504
- Sacred Heart Hospital
-
Pensacola, Florida, United States, 32501
- Baptist Hospital
-
Tallahassee, Florida, United States, 32308
- Tallahassee Memorial Hospital
-
Tampa, Florida, United States, 33613
- Pepin Heart Hospital
-
Winter Haven, Florida, United States, 33881
- Winter Haven Hospital
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory University Hospital
-
Atlanta, Georgia, United States, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, United States, 30309
- Piedmont Hospital Research Institute
-
Macon, Georgia, United States, 31201
- Medical Center Central Georgia
-
Rome, Georgia, United States, 30165
- Redmond Regional Hospital
-
-
Illinois
-
Barrington, Illinois, United States, 60010
- Advocate Good Shephard Hospital
-
Chicago, Illinois, United States, 60612
- University of Illinois at Chicago
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
Chicago, Illinois, United States, 60612
- Jesse Brown VA Medical Center
-
Downers Grove, Illinois, United States, 60515
- Good Samaritan Hospital- IL
-
Elmhurst, Illinois, United States, 60126
- Elmhurst Memorial Hospital
-
Joliet, Illinois, United States, 60435
- Heartland Education and Research Foundation
-
Maywood, Illinois, United States, 60153
- Loyola University Medical Center
-
Mokena, Illinois, United States, 60448
- Heart Care Research Foundation
-
Naperville, Illinois, United States, 60540
- Edward Heart Hospital
-
-
Indiana
-
Elkhart, Indiana, United States, 46541
- Midwest Cardiovascular Research and Education Foundation
-
Indianapolis, Indiana, United States, 46290
- St. Vincent Heart Center of Indiana, LLC
-
Valparaiso, Indiana, United States, 46383
- Northwest Indiana Cardiovascular Physicians, P.C.
-
-
Iowa
-
Ames, Iowa, United States, 50010
- McFarland Clinic PC
-
Cedar Rapids, Iowa, United States, 52403
- St. Luke's Hospital - Cedar Rapids
-
West Des Moines, Iowa, United States, 50266
- Iowa Heart Center
-
-
Kentucky
-
Ashland, Kentucky, United States, 41101
- Kings Daughters Medical Center
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70112
- Tulane University Medical School
-
-
Maine
-
Bangor, Maine, United States, 04401
- Northeast Cardiology Associates
-
Portland, Maine, United States, 04102
- Maine Medical Center
-
-
Maryland
-
Baltimore, Maryland, United States, 21218
- Union Memorial Hospital
-
Baltimore, Maryland, United States, 21215
- Sinai Hospital at Baltimore
-
Prince Frederick, Maryland, United States, 20678
- Shah Associates, LLC
-
Salisbury, Maryland, United States, 21804
- Peninsula Regional Medical Center
-
Takoma Park, Maryland, United States, 20912
- Washington Adventist Hospital
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
Boston, Massachusetts, United States, 02120
- Brigham and Women's Hospital
-
Burlington, Massachusetts, United States, 01805
- Lahey Clinic Medical Center
-
Hyannis, Massachusetts, United States, 02601
- Cape Cod Hospital
-
Worcester, Massachusetts, United States, 01655
- UMASS Memorial Medical Center
-
-
Michigan
-
Bay City, Michigan, United States, 48708
- Bay Regional Medical Center
-
Detroit, Michigan, United States, 48201-2018
- Harper University Hospital
-
Detroit, Michigan, United States, 48202
- Henry Ford Hospital Heart & Vascular Institute
-
Kalamazoo, Michigan, United States, 49048
- Borgess Medical Center
-
Pontiac, Michigan, United States, 48341
- St. Joseph Mercy-PTCMI
-
Royal Oak, Michigan, United States, 48073-6769
- William Beaumont Hospital
-
Saginaw, Michigan, United States, 48602
- Covenant Medical Center
-
Saint Joseph, Michigan, United States, 49085
- Great Lakes Heart & Vascular Institute, Pc
-
Traverse City, Michigan, United States, 49684
- Munson Medical Center
-
Troy, Michigan, United States, 48085
- Beaumont Hospital Troy
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic - Saint Marys Hospital
-
Saint Cloud, Minnesota, United States, 56303
- Central Minnesota Heart Center at St. Cloud Hospital
-
-
Mississippi
-
Hattiesburg, Mississippi, United States, 39401
- Hattiesburg Clinic
-
Tupelo, Mississippi, United States, 38801
- Cardiology Associates Research LLC
-
-
Missouri
-
Kansas City, Missouri, United States, 64114
- Kansas City Heart Foundation
-
Kansas City, Missouri, United States, 64111
- St. Luke's Hospital Mid America Heart Institute
-
North Kansas City, Missouri, United States, 64116
- North Kansas City Hospital
-
Saint Louis, Missouri, United States, 63110
- St. Louis University Hospital
-
Saint Louis, Missouri, United States, 63141
- St. John's Mercy Medical Center
-
Saint Louis, Missouri, United States, 63110-1093
- Washington University Hospital
-
Springfield, Missouri, United States, 65807
- St. John's Medical Institute
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68526
- Nebraska Heart Institute
-
Omaha, Nebraska, United States, 68131
- Creighton University
-
Omaha, Nebraska, United States, 68124
- Alegent Health / Bergan Mercy Hospital
-
-
New Hampshire
-
Manchester, New Hampshire, United States, 03102
- Catholic Medical Center
-
-
New Jersey
-
Camden, New Jersey, United States, 08103
- Cooper University Hospital
-
Haddon Heights, New Jersey, United States, 08035
- Cardiovascular Associates of the Delaware Valley, PA
-
Hamilton, New Jersey, United States, 08690
- Hamilton Cardiology Associates
-
Hawthorne, New Jersey, United States, 07506
- Valley Hospital
-
New Brunswick, New Jersey, United States, 08901
- UMDNJ - Robert Wood Johnson Medical School
-
Newark, New Jersey, United States, 07102
- St. Michaels Hospital
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87106
- Presbyterian Heart Group
-
-
New York
-
Liverpool, New York, United States, 13088
- SJH Cardiology Associates
-
Mineola, New York, United States, 11501
- Winthrop University Hospital
-
Poughkeepsie, New York, United States, 12601
- Hudson Valley Heart Center
-
Stony Brook, New York, United States, 11794-8167
- Stony Brook University Medical Center
-
Utica, New York, United States, 13501
- St. Elizabeth's Medical Center- NY
-
Valhalla, New York, United States, 10595
- Westchester Medical Center
-
-
North Carolina
-
Asheville, North Carolina, United States, 28802
- Asheville Cardiology Associates
-
Charlotte, North Carolina, United States, 28203
- Carolinas Medical Center
-
Gastonia, North Carolina, United States, 28054
- Carolina Heart Specialists
-
High Point, North Carolina, United States, 27262
- Carolina Cardiology Associates
-
Raleigh, North Carolina, United States, 27610
- Wake Heart Association
-
Winston-Salem, North Carolina, United States, 27103
- Forsyth Medical Center
-
Winston-Salem, North Carolina, United States, 27157-1045
- Wake Forest Health Sciences
-
-
North Dakota
-
Fargo, North Dakota, United States, 58122
- MeritCare Medical Center
-
Grand Forks, North Dakota, United States, 58206
- Altru Health System
-
-
Ohio
-
Cincinnati, Ohio, United States, 45220
- Good Samaritan Hospital
-
Cincinnati, Ohio, United States, 45267-0542
- University of Cincinnati Medical Center
-
Cincinnati, Ohio, United States, 45219
- The Lindner Clinical Trial Center
-
Columbus, Ohio, United States, 43214
- Riverside Methodist
-
Elyria, Ohio, United States, 44035
- Elyria Memorial Hospital
-
Marion, Ohio, United States, 43302
- Frederick C Smith Clinic dba Smith Clinic
-
Toledo, Ohio, United States, 43615
- Northwest Ohio Cardiology
-
-
Oklahoma
-
Midwest City, Oklahoma, United States, 73110
- Midwest Regional Medical Center
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, United States, 73120
- Oklahoma Foundation for CV Research
-
-
Oregon
-
Portland, Oregon, United States, 97225
- St. Vincent Hospital/ Providence Heart Hospital
-
Portland, Oregon, United States, 97239-3098
- Oregon Health & Sciences University Hospital
-
-
Pennsylvania
-
Abington, Pennsylvania, United States, 19001
- Abington Memorial Hospital
-
Chambersburg, Pennsylvania, United States, 17201
- Chambersburg Hospital
-
Danville, Pennsylvania, United States, 17822
- Geisinger Clinic
-
Doylestown, Pennsylvania, United States, 18901
- Doylestown Hospital
-
Harrisburg, Pennsylvania, United States, 17110
- Pinnacle Health Hospital
-
Johnstown, Pennsylvania, United States, 15905
- Conemaugh Memorial Medical Center
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC Presbyterian Hospital
-
Sayre, Pennsylvania, United States, 18840
- Donald Guthrie Foundation for Education and Research
-
Wyomissing, Pennsylvania, United States, 19610
- Berks Cardiologists
-
York, Pennsylvania, United States, 17403
- York Hospital (PA)
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Rhode Island Hospital
-
Providence, Rhode Island, United States, 02904
- Miriam Hospital
-
-
South Carolina
-
Anderson, South Carolina, United States, 29621
- AnMed Health
-
-
South Dakota
-
Rapid City, South Dakota, United States, 57701
- Black Hills Research- Rapid City Regional
-
Sioux Falls, South Dakota, United States, 57117
- Sanford USD Medical Center
-
Sioux Falls, South Dakota, United States, 57105
- North Central Heart Institute
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Chattanooga Heart Institute
-
Chattanooga, Tennessee, United States, 37404
- Chattanooga Heart - East Third Street
-
Nashville, Tennessee, United States, 37203
- Centennial Heart Medical Center
-
-
Texas
-
Austin, Texas, United States, 78705
- Austin Heart
-
Austin, Texas, United States, 78745
- Capital Cardiovascular Research Institute
-
Austin, Texas, United States, 78758
- Texas Cardiovascular
-
Dallas, Texas, United States, 75390
- UT Southwestern Medical Center
-
Dallas, Texas, United States, 75216
- Veteran's Affairs Medical Center- Dallas
-
Dallas, Texas, United States, 75230
- CRSTI Research
-
Houston, Texas, United States, 77030
- Methodist DeBakey Heart & Vascular Center
-
McKinney, Texas, United States, 75069
- North Dallas Research Associates
-
McKinney, Texas, United States, 75069
- North Dallas Research Associate
-
Plano, Texas, United States, 75093
- The Heart Hospital / Baylor Plano
-
Round Rock, Texas, United States, 78665
- Scott and White Healthcare - Round Rock
-
San Antonio, Texas, United States, 78229
- TexSAn Heart Hospital
-
Tyler, Texas, United States, 75701
- Mother Frances Hospital
-
Waco, Texas, United States, 76712
- Providence Healthcare Network
-
-
Utah
-
Murray, Utah, United States, 84157-7000
- Intermountain Medical Center
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia
-
Harrisonburg, Virginia, United States, 22801
- Rockingham Memorial Hospital
-
Lynchburg, Virginia, United States, 24501
- Lynchburg General Hospital
-
Norfolk, Virginia, United States, 23507
- Sentara, Norfolk General Hospital
-
Roanoke, Virginia, United States, 24014
- Carilion Clinic
-
Virginia Beach, Virginia, United States, 23454
- Cardiovascular Associates, Ltd.
-
Winchester, Virginia, United States, 22601
- Winchester Medical Center
-
-
Washington
-
Olympia, Washington, United States, 98506
- Providence St. Peter Hospital
-
Seattle, Washington, United States, 98195-8422
- University of Washington
-
Spokane, Washington, United States, 99204
- Sacred Heart Medical Center
-
Spokane, Washington, United States, 99204
- Inland Cardiology Associates
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53215
- Aurora St. Luke's Medical Center
-
Wausau, Wisconsin, United States, 54401
- CaRE Foundation, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria (Enrollment):
- Subject is > 18 years of age.
- Subjects undergoing percutaneous intervention with stent deployment (or has w/in 24 hours).
- Subjects without known contraindication to dual antiplatelet therapy for at least 30 months after enrollment and stent implantation.
- The subject has consented to participate and has authorized the collection and release of his medical information by signing the "Patient Informed Consent Form". The informed consent will be valid for the duration of the trial or until the subject withdraws.
Inclusion Criterion (Randomization at 12 months):
1. Subject, at 12 months, is free from death, MI, stroke, repeat coronary revascularization, major bleeding, and stent thrombosis and has been compliant with dual antiplatelet therapy following stent implantation.
Exclusion Criteria (Enrollment):
- Index procedure stent placement with stent diameter <2.25 mm or >4.0 mm.
- Pregnant women.
- Planned surgery necessitating discontinuation of antiplatelet therapy within the 30 months following enrollment.
- Current medical condition with a life expectancy of less than 3 years.
- Concurrent enrollment in another device or drug study whose protocol specifically excludes concurrent enrollment or that involves blinded placement of a DES or BMS other than those included as DAPT Study devices. The subject may only be enrolled in the DAPT Study once.
- Subjects on warfarin or similar anticoagulant therapy.
- Subjects with hypersensitivity or allergies to one of the drugs or components indicated in the Instructions for Use for the device implanted.
- Subjects unable to give informed consent.
- Subject treated with both DES and BMS during the index procedure.
Exclusion Criteria (Randomization at 12 months):
- Pregnant women.
- Subject switched thienopyridine type or dose within 6 months prior to randomization.
- Percutaneous coronary intervention or cardiac surgery between 6 weeks post index procedure and randomization.
- Planned surgery necessitating discontinuation of antiplatelet therapy within the 21 months following randomization.
- Current medical condition with a life expectancy of less than 3 years.
- Subjects on warfarin or similar anticoagulant therapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: 12m DAPT Study Arm
This population consists of subjects enrolled in the study who are free from death, MI, stroke, repeat coronary revascularization, major bleeding, and ST 12 months after stent implantation and who are compliant with 12 months of dual antiplatelet therapy following stent implantation and who are subsequently randomized to receive 18 months of placebo treatment in addition to aspirin.
|
|
Active Comparator: 30m DAPT Study Arm
This population consists of subjects enrolled in the study who are free from death, MI, stroke, repeat coronary revascularization, major bleeding, and ST 12 months after stent implantation and who are compliant with 12 months of dual antiplatelet therapy following stent implantation and who are subsequently randomized to receive an additional 18 months of thienopyridine treatment in addition to aspirin.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT
Time Frame: 18 months (12-30 months post-index procedure)
|
The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of ARC definite or probable stent thrombosis within randomized DES ITT patients between 12 and 30 months post procedure.
|
18 months (12-30 months post-index procedure)
|
Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT
Time Frame: 18 months (12-30 months post-index procedure)
|
The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of definite or probable ST within randomized DES ITT patients between 12 and 30 months post procedure.
ST was assessed according to the Academic Research Consortium (ARC) definitions.
|
18 months (12-30 months post-index procedure)
|
GUSTO Severe or Moderate Bleeding - Randomized DES ITT
Time Frame: 18 months (12-30 months post-index procedure)
|
The primary safety endpoint was moderate or severe bleeding within randomized DES ITT patients between 12 and 30 months post procedure.
Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.
|
18 months (12-30 months post-index procedure)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MACCE (Death, Myocardial Infarction or Stroke) - Propensity Matched DES vs. BMS
Time Frame: 33 months (0-33 months post-index procedure)
|
Secondary powered endpoint
|
33 months (0-33 months post-index procedure)
|
Definite or Probable Stent Thrombosis (ST) - Propensity Matched DES vs. BMS
Time Frame: 33 months (0-33 months post-index procedure)
|
Secondary powered endpoint
|
33 months (0-33 months post-index procedure)
|
MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT
Time Frame: 21 months (12-33 months post-index procedure)
|
21 months (12-33 months post-index procedure)
|
|
Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT
Time Frame: 21 months (12-33 months post-index procedure)
|
ST was assessed according to the Academic Research Consortium (ARC) definitions.
|
21 months (12-33 months post-index procedure)
|
GUSTO Severe or Moderate Bleeding - Randomized DES ITT
Time Frame: 21 months (12-33 months post-index procedure)
|
Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.
|
21 months (12-33 months post-index procedure)
|
MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT
Time Frame: 18 months (12-30 months post-index procedure)
|
18 months (12-30 months post-index procedure)
|
|
Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT
Time Frame: 18 months (12-30 months post-index procedure)
|
ST was assessed according to the Academic Research Consortium (ARC) definitions.
|
18 months (12-30 months post-index procedure)
|
GUSTO Severe or Moderate Bleeding - Randomized BMS ITT
Time Frame: 18 months (12-30 months post-index procedure)
|
Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.
|
18 months (12-30 months post-index procedure)
|
MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT
Time Frame: 21 months (12-33 months post-index procedure)
|
21 months (12-33 months post-index procedure)
|
|
Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT
Time Frame: 21 months (12-33 months post-index procedure)
|
ST was assessed according to the Academic Research Consortium (ARC) definitions.
|
21 months (12-33 months post-index procedure)
|
GUSTO Severe or Moderate Bleeding - Randomized BMS ITT
Time Frame: 21 months (12-33 months post-index procedure)
|
Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.
|
21 months (12-33 months post-index procedure)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Laura Mauri, MD, MSc, Brigham and Women's Hospital
- Principal Investigator: Dean Kereiakes, MD, FACC, Christ Hospital Heart and Vascular Center
Publications and helpful links
General Publications
- Berg DD, Yeh RW, Mauri L, Morrow DA, Kereiakes DJ, Cutlip DE, Gao Q, Jarolim P, Michelson AD, Frelinger AL 3rd, Cange AL, Sabatine MS, O'Donoghue ML. Biomarkers of platelet activation and cardiovascular risk in the DAPT trial. J Thromb Thrombolysis. 2021 Apr;51(3):675-681. doi: 10.1007/s11239-020-02221-5.
- Stefanescu Schmidt AC, Steg PG, Yeh RW, Kereiakes DJ, Tanguay JF, Hsieh WH, Massaro JM, Mauri L, Cutlip DE; DAPT Investigators. Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study). Am J Cardiol. 2019 Dec 15;124(12):1813-1820. doi: 10.1016/j.amjcard.2019.09.006. Epub 2019 Sep 26.
- Berry NC, Kereiakes DJ, Yeh RW, Steg PG, Cutlip DE, Jacobs AK, Abbott JD, Hsieh WH, Massaro JM, Mauri L; DAPT Study Investigators. Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women. Circ Cardiovasc Interv. 2018 Aug;11(8):e005308. doi: 10.1161/CIRCINTERVENTIONS.117.005308.
- Yeh RW, Kereiakes DJ, Steg PG, Cutlip DE, Croce KJ, Massaro JM, Mauri L; DAPT Study Investigators. Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2017 Oct 31;70(18):2213-2223. doi: 10.1016/j.jacc.2017.09.011.
- Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Cohen DJ, Steg PG, Cannon CP, Apruzzese PK, D'Agostino RB Sr, Massaro JM, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. JAMA Cardiol. 2017 May 1;2(5):478-487. doi: 10.1001/jamacardio.2017.0063.
- Stefanescu Schmidt AC, Kereiakes DJ, Cutlip DE, Yeh RW, D'Agostino RB Sr, Massaro JM, Hsieh WH, Mauri L; DAPT Investigators. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy). Circulation. 2017 May 2;135(18):1720-1732. doi: 10.1161/CIRCULATIONAHA.116.024835. Epub 2017 Feb 22.
- Resor CD, Nathan A, Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Gabriel Steg P, Hsieh WH, Mauri L; Dual Antiplatelet Therapy Study Investigators. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study. Circulation. 2016 Oct 4;134(14):989-998. doi: 10.1161/CIRCULATIONAHA.116.024531. Epub 2016 Aug 30.
- Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Steg PG, Wiviott SD, Mauri L; DAPT Study Investigators. DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction. J Am Coll Cardiol. 2016 May 31;67(21):2492-502. doi: 10.1016/j.jacc.2016.03.485. Epub 2016 Apr 1.
- Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L; DAPT Study Investigators. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775. Erratum In: JAMA. 2016 Jul 19;316(3):350. JAMA. 2016 Jul 19;316(3):350.
- Meredith IT, Tanguay JF, Kereiakes DJ, Cutlip DE, Yeh RW, Garratt KN, Lee DP, Steg PG, Weaver WD, Holmes DR Jr, Brindis RG, Trebacz J, Massaro JM, Hsieh WH, Mauri L; DAPT Study Investigators. Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study. Circulation. 2016 May 3;133(18):1772-82. doi: 10.1161/CIRCULATIONAHA.115.016783. Epub 2016 Mar 18. Erratum In: Circulation. 2016 May 31;133(22):e671.
- Hermiller JB, Krucoff MW, Kereiakes DJ, Windecker S, Steg PG, Yeh RW, Cohen DJ, Cutlip DE, Massaro JM, Hsieh WH, Mauri L; DAPT Study Investigators. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. JACC Cardiovasc Interv. 2016 Jan 25;9(2):138-47. doi: 10.1016/j.jcin.2015.10.001.
- Mauri L, Elmariah S, Yeh RW, Cutlip DE, Steg PG, Windecker S, Wiviott SD, Cohen DJ, Massaro JM, D'Agostino RB Sr, Braunwald E, Kereiakes DJ; DAPT Study Investigators. Causes of late mortality with dual antiplatelet therapy after coronary stents. Eur Heart J. 2016 Jan 21;37(4):378-85. doi: 10.1093/eurheartj/ehv614. Epub 2015 Nov 18.
- Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; DAPT Study Investigators. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026. Erratum In: JACC Cardiovasc Interv. 2015 Dec 21;8(14):1913.
- Yeh RW, Kereiakes DJ, Steg PG, Windecker S, Rinaldi MJ, Gershlick AH, Cutlip DE, Cohen DJ, Tanguay JF, Jacobs A, Wiviott SD, Massaro JM, Iancu AC, Mauri L; DAPT Study Investigators. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. J Am Coll Cardiol. 2015 May 26;65(20):2211-21. doi: 10.1016/j.jacc.2015.03.003. Epub 2015 Mar 15.
- Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum In: JAMA. 2015 Jun 2;313(21):2185. JAMA. 2016 Jul 5;316(1):105. JAMA. 2016 Jul 5;316(1):105.
- Yeh RW, Czarny MJ, Normand SL, Kereiakes DJ, Holmes DR Jr, Brindis RG, Weaver WD, Rumsfeld JS, Roe MT, Kim S, Driscoll-Shempp P, Mauri L. Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):96-102. doi: 10.1161/CIRCOUTCOMES.114.001239. Epub 2014 Nov 16.
- Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.
- Matteau A, Yeh RW, Kereiakes D, Orav EJ, Massaro J, Steg PG, Normand SL, Cutlip DE, Mauri L. Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study). Am J Cardiol. 2014 Apr 1;113(7):1146-52. doi: 10.1016/j.amjcard.2013.10.015. Epub 2013 Nov 8.
- Mauri L, Kereiakes DJ, Normand SL, Wiviott SD, Cohen DJ, Holmes DR, Bangalore S, Cutlip DE, Pencina M, Massaro JM. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J. 2010 Dec;160(6):1035-41, 1041.e1. doi: 10.1016/j.ahj.2010.07.038.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
- Myocardial infarction
- Everolimus
- Prasugrel
- Percutaneous coronary intervention
- Drug Eluting Stent
- Acute Coronary Syndrome
- Sirolimus
- Paclitaxel
- Adverse event
- Clopidogrel
- Stent Thrombosis
- Bare Metal Stent
- Myocardial ischemia
- Dual antiplatelet therapy
- Antiplatelet therapy
- Zotarolimus
- Major Bleeding
- Thienopyridine
- Clinical Events Committee
- Harvard Clinical Research Institute
- Major Adverse Cardiac and Cerebral Event
- Stent placement
Additional Relevant MeSH Terms
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Coronary Disease
- Coronary Artery Disease
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Fibrinolytic Agents
- Fibrin Modulating Agents
- Platelet Aggregation Inhibitors
- Cyclooxygenase Inhibitors
- Antipyretics
- Purinergic P2Y Receptor Antagonists
- Purinergic P2 Receptor Antagonists
- Purinergic Antagonists
- Purinergic Agents
- Aspirin
- Clopidogrel
- Prasugrel Hydrochloride
Other Study ID Numbers
- HCRIG080186
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
San Luigi Gonzaga HospitalRecruitingCoronary Disease | STEMI | Coronary Artery Ectasia | Right Coronary Artery Occlusion | Right Coronary Artery StenosisSpain, Italy
Clinical Trials on Placebo & Aspirin
-
Queen Mary University of LondonCancer Research UK; Barts and the London School of Medicine and DentistryCompletedProstate CancerUnited Kingdom
-
Seoul National University HospitalCKD Pharmaceutical LimitedCompleted
-
Woo Hyun PaikTerminatedBiliary Stasis, ExtrahepaticKorea, Republic of
-
University College, LondonRecruitingCancer | Breast Cancer | Colorectal Cancer | Prostate Cancer | Gastro-oesophageal CancerIreland, United Kingdom
-
Dave HostlerFederal Emergency Management Administration; Eyemarker Systems, IncCompletedHeat Stress DisordersUnited States
-
The First Affiliated Hospital with Nanjing Medical...UnknownCoronary AtherosclerosisChina
-
Columbia UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Oxford University Clinical Research Unit, VietnamHospital for Tropical Diseases, Ho Chi Minh City, VietnamCompletedTuberculous MeningitisVietnam
-
University Hospital, BrestBayerRecruiting